Diagens-B Sustainability Reports
The company operates as a medical device and imaging artificial intelligence (AI) enterprise developing products for clinical genetic diagnosis. It specializes in AI-assisted chromosome karyotyping diagnostic software, medical imaging systems, consumables, and model-as-a-service configurations.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG020PPZKJ1
1 reports from 2025 to 2025
